Loading...
Warfarin — Export Intelligence Report
2025-Q4 · TransData Nexus
PHARMA TRADE INTELLIGENCE
INDIA EXPORT INTELLIGENCE REPORT
Warfarin
2025-Q4
Comprehensive analysis of India’s warfarin export trade — suppliers, buyers, prices, routes, and every shipment record.
143
Shipments
$1.22M
Trade Value
25
Suppliers
24
Buyers
21
Countries
Scan for online report
Talk to our analyst: +91 95950 78788
https://transdatanexus.com/pharmaceutical/warfarin
01
PART I — OVERVIEW
Executive Summary
At-a-glance KPIs, key findings, and strategic positioning of India’s warfarin trade — 2025-Q4
KEY TAKEAWAY
Warfarin 2025-Q4 exports total $1.2M across 21 countries, with CIPLA LTD commanding 61.8% market share.
TOTAL SHIPMENTS
143
2025-Q4
EXPORT VALUE
$1.2M
FOB USD
TOTAL QUANTITY
27.6M
units shipped
INDIAN SUPPLIERS
25
unique exporters
GLOBAL BUYERS
24
unique importers
DESTINATIONS
21
countries
MEDIAN UNIT PRICE
$0.435
per unit
TOP-5 SHARE
99.1%
of total USD
BRANDED SHARE
60.1%
86 shipments
DOSAGE FORMS
2
product types
6 KEY FINDINGS
1
CIPLA LTD is India's #1 Warfarin exporter with $753.2K (61.8% market share).→ §5, Indian Supplier Rankings
2
Warfarin reached 21 countries, with South Africa as the top destination ($514.8K).→ §4, Global Destination Map
3
Market concentration is high (HHI: 4671) — top 10 suppliers control 99.9% of exports.→ §5, Indian Supplier Rankings
4
83.3% of buyers (20 of 24) source from a single Indian supplier — potential poaching opportunities.→ §6, Global Buyer Rankings
5
Tablet dominates (98.6%) across 2 dosage forms.→ §7, Price Benchmarks
6
21 countries have ≤5 Indian suppliers — easy-entry markets for SME exporters.→ §9, Strategic Opportunities
WHO THIS REPORT IS FOR
S SUPPLIERS (Indian pharma exporters)
- See which buyers your competitors are shipping to, at what price, through which ports
- Identify buyers that are single-sourced (poaching opportunities)
- Benchmark your pricing and catalog vs the Top 25
B BUYERS (global importers)
- Discover which Indian exporters supply this product and what they sell
- Benchmark the price you are paying vs the market median by country and dosage
- Identify alternative suppliers with proven exports to similar destinations
Figure 1.1 CIPLA LTD leads in volume — how do 25 exporters compare on price × volume?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Every bubble is one Indian warfarin exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.
HOW TO READ THIS REPORT
60 seconds
Scan this page — KPIs, thesis, flagship chart, top findings
5 minutes
Read every Key Takeaway line across §1–§9
30 minutes
Read sections tagged for your role ([S] or [B]) end-to-end
In depth
Drill into §10 for your country · supplier / buyer directories at end
02
PART I — OVERVIEW
About This Report
Data sources, methodology, trust signals, and what this Warfarin report covers
KEY TAKEAWAY
Every figure in this report is grounded in real commercial warfarin trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.
S FOR SUPPLIERS
Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.
B FOR BUYERS
Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian warfarin suppliers.
§2.1 Reporting parameters · the scope of this 2025-Q4 Warfarin India trade report
Product scope
Warfarin
All variants merged — branded and generic formulations of warfarin
Time period
2025-Q4
October, November, December 2025 — a single-quarter snapshot
Data sources
Official & public trade records
Government customs filings, public trade databases and licensed commercial feeds
Geography
India origin → global
Indian sea and air ports shipping to destination markets worldwide
Currency
USD (FOB)
Declared Free-on-Board value at the Indian port of loading
Shipments analysed
143
Every commercial warfarin trade record in the period, aggregated and deduplicated
§2.2 Our quality process · Figure 2.1
Figure 2.1 From raw trade records to a clean report — the four quality pillars.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.
§2.3 Trust signals · what you can rely on in the numbers you read
DATA COVERAGE
10M+
Pharmaceutical trade records across the full TransData Nexus platform.
COUNTRIES
150+
Origin and destination countries covered in the global pharma trade database.
DATA ACCURACY
99.9%
Validation rate on core fields — supplier, buyer, product, quantity, value.
UPDATE FREQUENCY
Daily
Platform refresh cadence. This report is a snapshot from the same live data.
§2.4 Limitations · what the data does and does not tell you
WHAT THIS DATA DOES AND DOES NOT SAY
- Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
- This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
- A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
- This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.
03
PART II — MARKET STRUCTURE
Quarterly Trade Overview
Monthly trends, regional performance, and ranking shifts — 2025-Q4
KEY TAKEAWAY
2025-Q4 followed a mixed: Oct $40.6K, Nov $1.1M, Dec $87.7K. Shipment counts rose across the quarter.
S FOR SUPPLIERS
Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.
B FOR BUYERS
Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.
1
$40.6K
Oct USD
8 shipments
2
$1.1M
Nov USD
+2585.4% MoM
3
$87.7K
Dec USD
-92.0% MoM
4
Mixed
Q4 growth shape
Oct → Nov → Dec
Fig 3.1 Nov rose 2585.4% in USD but shipment count kept climbing.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $41K, making it the weakest month by value.
Fig 3.2 Q4 cumulative USD reached $1.2M.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.
Fig 3.3 $1.1M rise in Nov, $1.0M decline in Dec.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = absolute monthly value. Red = month-over-month loss; green = gain. Insight: Trade grew steadily across the quarter.
Fig 3.4 Regional breakdown by month — which corridors swung most?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.
§3.1 Monthly summary
| Oct | $41K | 8 shipments |
| Nov | $1.1M | 95 shipments |
| Dec | $88K | 40 shipments |
| Q4 Total | $1.2M | 143 shipments |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 3.5 Top 10 destination countries by monthly USD rank — who’s rising?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a country’s monthly rank. Lines crossing = rank swaps. Insight: United States held #1 throughout the quarter.
Fig 3.6 Top 10 Indian exporters by monthly USD rank.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: MACLEODS PHARMACEUTICALS LTD maintained its leading position.
04
PART II — MARKET STRUCTURE
Global Destination Map
Which countries import warfarin from India, how much they buy, and who supplies each market
KEY TAKEAWAY
South Africa absorbs 42.2% of India’s 2025-Q4 warfarin trade ($514.8K). Beyond the top 10 destinations, 21 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Africa has 7 destination countries, the widest regional diversity.
S FOR SUPPLIERS
Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 21 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.
B FOR BUYERS
Find your country on the map to see how much warfarin India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.
Asia
$335K
27.4% of trade
5 countries · 55 shipments
Americas
$358K
29.4% of trade
7 countries · 41 shipments
Africa
$526K
43.1% of trade
7 countries · 40 shipments
Oceania
$941
0.1% of trade
2 countries · 7 shipments
Fig 4.1 South Africa is the #1 corridor ($515K) — 21 flow arcs from India radiate across 4 continents.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The world map shows every country colored by how much Indian warfarin it receives (light = low, dark = high). Orange arcs radiate from India to the top 21 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.
§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers
| # | Destination | Total USD | Ships | #1 Indian supplier | USD | #2 Indian supplier | USD | #3 Indian supplier | USD |
|---|---|---|---|---|---|---|---|---|---|
| 1 | South Africa | $515K | 16 | CIPLA LTD | $515K | — | — | — | — |
| 2 | United States | $349K | 26 | AMNEAL PHARMACEUTICALS PVT LTD | $349K | — | — | — | — |
| 3 | Sri Lanka | $238K | 10 | CIPLA LTD | $238K | — | — | — | — |
| 4 | Jordan | $59K | 3 | MACLEODS PHARMACEUTICALS LTD | $59K | — | — | — | — |
| 5 | Philippines | $33K | 1 | AJANTA PHARMA LTD | $33K | — | — | — | — |
| 6 | Chile | $9K | 3 | MACLEODS PHARMACEUTICALS LTD | $9K | — | — | — | — |
| 7 | Kenya | $6K | 2 | NAMAN PHARMA DRUGS | $5K | AFRO LIFESCIENCE | $394 | — | — |
| 8 | Nigeria | $5K | 1 | CARIESCO EXPORTS | $5K | — | — | — | — |
| 9 | Myanmar | $4K | 2 | DREAM PHARMACEUTICAL | $2K | SCOTT EDIL PHARMACIA LTD | $2K | — | — |
| 10 | Nauru | $612 | 2 | HLL LIFECARE LTD | $612 | — | — | — | — |
Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.
Fig 4.2 Asia leads at 27.4% of USD — but South Africa is the single largest market.
Region → country treemap
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.
§4.2 Destination concentration
42.2%
#1 country share
South Africa alone
97.9%
Top 5 share
5 of 21 countries
100.0%
Top 15 share
Long tail of 6 countries = 0.0%
HHI 3013
Destination HHI
Highly concentrated
21
Countries served
Global pharma reach from India
7
Africa countries
Widest regional diversity
Source: TransData Nexus trade data platform
05
PART III — WHO’S IN THIS MARKET
Indian Supplier Rankings & Profiles
25 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence
KEY TAKEAWAY
CIPLA LTD ($753.2K, 61.8% share) and AMNEAL PHARMACEUTICALS PVT LTD ($348.6K) together control 90.4% of India’s 2025-Q4 warfarin trade. The top 5 suppliers hold 99.1%. 25 companies shipped at least once.
S FOR SUPPLIERS
Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.
B FOR BUYERS
Find potential Indian warfarin suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.
Fig 5.1 CIPLA LTD leads by $405K over AMNEAL PHARMACEUTICALS PVT LTD — top 20 Indian exporters ranked by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: DERRIC WOOD is #12 by value but #1 by volume.
Fig 5.2 DERRIC WOOD also leads by shipment count (37) but ranking shifts for volume-heavy players
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: DERRIC WOOD moves from #1 by volume to #12 by value — fewer but higher-value shipments.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — Archetypes & Concentration
How India’s 25 warfarin suppliers split into strategic segments
KEY TAKEAWAY
7 suppliers (25%) generate 99.7% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.
Fig 5.3 CIPLA LTD and AMNEAL PHARMACEUTICALS PVT LTD sit in the leaders zone — high volume AND high value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.
Fig 5.4 25% of suppliers = 99.7% of USD — classic concentration.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Top bar = supplier %, bottom bar = USD %. The gap = market concentration.
Product variety — how many formulations each supplier ships
| # | Supplier | Dosage forms | Countries | USD |
|---|---|---|---|---|
| 1 | AMNEAL PHARMACEUTICALS PVT LTD | 2 | 1 | $349K |
| 2 | CIPLA LTD | 1 | 2 | $753K |
| 3 | MACLEODS PHARMACEUTICALS LTD | 1 | 2 | $69K |
| 4 | AJANTA PHARMA LTD | 1 | 1 | $33K |
| 5 | NAMAN PHARMA DRUGS | 1 | 1 | $5K |
| 6 | CARIESCO EXPORTS | 1 | 1 | $5K |
| 7 | DREAM PHARMACEUTICAL | 1 | 1 | $2K |
| 8 | SCOTT EDIL PHARMACIA LTD | 1 | 1 | $2K |
| 9 | HLL LIFECARE LTD | 1 | 2 | $625 |
| 10 | AFRO LIFESCIENCE | 1 | 2 | $501 |
Table 5.1 — The more dosage forms a supplier ships, the more versatile their manufacturing capability.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — India Origin Geography & Concentration
Which Indian cities and states are the warfarin manufacturing hubs
KEY TAKEAWAY
Parel Mumbai Maharashtra and Park together account for $738K of India’s 2025-Q4 warfarin trade.
Fig 5.5 Parel Mumbai Maharashtra (1 exporters, $480K) and Park (1 exporters, $257K) are India’s warfarin capitals.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Orange bubbles mark major pharma hub cities; bubble size = USD value. Every hub labeled.
§5.1 Supplier concentration metrics
99.1%
Top 5 share
5 of 25 suppliers
99.9%
Top 10 share
10 of 25 suppliers
99.7%
Top 25% share
7 suppliers = 100% USD
HHI 4671
Supplier HHI
Concentrated
25
Total suppliers
shipped Warfarin in 2025-Q4
20+ cities
Indian hubs
Parel Mumbai Maharashtra and Park lead
§5.2 Coming next: 3 exporter deep-dive profiles
Each of the top 3 suppliers gets a dedicated 2-page profile with:
- 6 KPI cards — trade value, shipments, countries, buyers, avg ship value, branded share
- Dosage form breakdown — what formulations they ship
- Monthly trend — Oct / Nov / Dec trajectory
- Trade flow map — supplier → country → importer connections
- Buyer portfolio with lock-in analysis
SUPPLIER PROFILES IN THIS REPORT
| #1 | CIPLA LTD | $753K |
| #2 | MACLEODS PHARMACEUTICALS LTD | $69K |
| #3 | AFRO LIFESCIENCE | $501 |
#1
2025-Q4 USD
$753K
61.8% market share
SHIPMENTS
26
avg $29K/ship
COUNTRIES
2
destination markets
BUYERS
4
3 single-sourced
BRANDED
77%
of shipments
DOSAGE FORMS
1
product types
TOP 2 DESTINATIONS
South Africa is the #1 market at $515K (68% of trade), followed by Sri Lanka at $238K. 2 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | South Africa | $515K | 16 | 68.4% |
| 2 | Sri Lanka | $238K | 10 | 31.6% |
MONTHLY TREND
Nov peaked at $738K. Dec was the weakest at $0.
PRODUCT MIX
Tablet dominates at 100% of trade.
TOP BUYERS · 3/3 LOCKED IN
3 of 3 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| MEDPRO PHARMACEUTICA P… | South Africa | $257K | ⚠ Locked |
| Undisclosed buyer | South Africa | $257K | N/A |
| BREATHEFREE LANKA PVT … | Sri Lanka | $223K | ⚠ Locked |
| BREATHEFREE LANKA (PVT… | Sri Lanka | $15K | ⚠ Locked |
#1
EXPORTER PROFILE #1 OF 3 — TRADE FLOW MAP
CIPLA LTD — Supplier → Country → Importer
2 destination countries, top 5 importers per country
Fig 5.P1.3 South Africa absorbs $515K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 2 importers per destination.
#3
EXPORTER PROFILE #2 OF 3
MACLEODS PHARMACEUTICALS LTD
Baddi · India’s #3 warfarin supplier by USD · 2025-Q4
2025-Q4 USD
$69K
5.6% market share
SHIPMENTS
6
avg $11K/ship
COUNTRIES
2
destination markets
BUYERS
2
2 single-sourced
BRANDED
67%
of shipments
DOSAGE FORMS
1
product types
TOP 2 DESTINATIONS
Jordan is the #1 market at $59K (86% of trade), followed by Chile at $9K. 2 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Jordan | $59K | 3 | 86.1% |
| 2 | Chile | $9K | 3 | 13.9% |
MONTHLY TREND
Dec was the strongest month, ending the quarter on a high at $60K.
PRODUCT MIX
Tablet dominates at 100% of trade.
TOP BUYERS · 2/2 LOCKED IN
2 of 2 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| PHARMACARE DRUG STORE | Jordan | $59K | ⚠ Locked |
| VITAFARMA S.A | Chile | $9K | ⚠ Locked |
#3
EXPORTER PROFILE #2 OF 3 — TRADE FLOW MAP
MACLEODS PHARMACEUTICALS LTD — Supplier → Country → Importer
2 destination countries, top 5 importers per country
Fig 5.P2.3 Jordan absorbs $59K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 1 importers per destination.
#10
2025-Q4 USD
$501
0.0% market share
SHIPMENTS
9
avg $56/ship
COUNTRIES
2
destination markets
BUYERS
3
2 single-sourced
BRANDED
11%
of shipments
DOSAGE FORMS
1
product types
TOP 2 DESTINATIONS
Kenya is the #1 market at $394 (79% of trade), followed by Sudan at $108. 2 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Kenya | $394 | 1 | 78.5% |
| 2 | Sudan | $108 | 8 | 21.5% |
MONTHLY TREND
Dec was the strongest month, ending the quarter on a high at $394.
PRODUCT MIX
Tablet dominates at 100% of trade.
TOP BUYERS · 2/2 LOCKED IN
2 of 2 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| CYERDITTRADING CO LTD | Kenya | $394 | ⚠ Locked |
| MADAU KUAAC AYAI KON | Sudan | $81 | ⚠ Locked |
| Undisclosed buyer | Sudan | $27 | N/A |
#10
EXPORTER PROFILE #3 OF 3 — TRADE FLOW MAP
AFRO LIFESCIENCE — Supplier → Country → Importer
2 destination countries, top 5 importers per country
Fig 5.P3.3 Kenya absorbs $394 — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 2 importers per destination.
06
PART III — WHO’S IN THIS MARKET
Global Buyer Rankings & Intelligence
24 importers across 21 countries — who is buying Indian warfarin and how much
KEY TAKEAWAY
The demand side is dramatically more fragmented than supply: the top 22 importers together hold only 69.4% of total USD. 83% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.
S FOR SUPPLIERS
Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).
B FOR BUYERS
See where you rank among global importers of Indian warfarin. Compare your USD and shipment count against peers in your country and dosage segment.
Fig 6.1 MEDPRO PHARMACEUTICA PTY LTD is the #1 importer at $257K (21.1%) — top 22 by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one global importer ranked by USD.
Fig 6.2 Re-ranked by shipment count — compare with Fig 6.1 for divergences
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same 22 importers re-ranked by shipment count.
§6.1 Sourcing diversity — how many Indian suppliers does each buyer use?
83%
Single-source
20 buyers rely on exactly 1 Indian supplier
8%
Dual-source
2 buyers use 2 Indian suppliers
0%
Multi-source (3–4)
0 buyers diversified across 3–4
8%
Broad-source (5+)
2 buyers with 5+ Indian suppliers
06
PART III — WHO’S IN THIS MARKET
Single-Source Buyers & Price Benchmark
Lock-in opportunities grouped by country + where each buyer sits on the price spectrum
KEY TAKEAWAY
These importers source warfarin from exactly one Indian supplier. For each one, the table shows the incumbent, price, and dosage.
S FOR SUPPLIERS
This is your target list. Each row is a buyer locked into one competitor. Offer 5–10% better pricing to win the second-source slot.
B FOR BUYERS
If you see your company here, you are fully dependent on one Indian supplier. Consider qualifying a second source.
§6.2 Single-source lock-in by country
Sri Lanka 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| BREATHEFREE LANKA PVT … | CIPLA LTD | $223K | $0.029 | Tablet |
| BREATHEFREE LANKA (PVT… | CIPLA LTD | $15K | $0.016 | Tablet |
Sudan 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| QUEEENS ENTERPRISES CO… | BAKER & DAVIS PVT LTD | $109.814 | $0.110 | Tablet |
| MADAU KUAAC AYAI KON | AFRO LIFESCIENCE | $80.630 | $0.067 | Tablet |
Zambia 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| LUSAKA PHARMA CHEM SUP… | MEDICOS LIFESCIENCES | $18.214 | $0.091 | Tablet |
| LUSAKA MEDICAMP LTD | MEDICOS LIFESCIENCES | $17.351 | $0.087 | Tablet |
Somalia 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| MOHAMED AHEMED MOHAMUD | M T MADON EXPORTS | $2.000 | $0.0010 | Tablet |
| KALKAAL HOSPITAL | CURE EARTH PHARMA | $1.387 | $0.139 | Tablet |
South Africa 1 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| MEDPRO PHARMACEUTICA P… | CIPLA LTD | $257K | $0.034 | Tablet |
§6.3 Price positioning — top 22 importers
| # | Importer | Country | USD | $/ship | Tier |
|---|---|---|---|---|---|
| 1 | MEDPRO PHARMACEUTICA… | South Africa | $257K | $32K | Mid |
| 2 | AMNEAL PHARMACEUTICA… | United States | $247K | $12K | Budget |
| 3 | BREATHEFREE LANKA PV… | Sri Lanka | $223K | $28K | Mid |
| 4 | PHARMACARE DRUG STORE | Jordan | $59K | $20K | Mid |
| 5 | AJANTA PHARMA PHILIP… | Philippines | $33K | $33K | Mid |
| 6 | BREATHEFREE LANKA (P… | Sri Lanka | $15K | $8K | Budget |
| 7 | VITAFARMA S.A | Chile | $9K | $3K | Budget |
| 8 | REPUBLIC OF NAURU - … | Nauru | $611.959 | $306.000 | Budget |
| 9 | CYERDITTRADING CO LTD | Kenya | $393.708 | $394.000 | Budget |
| 10 | REPUBLIC OF NAURU, D… | Australia | $236.039 | $59.000 | Budget |
| 11 | GOOD HEALTH (PTY) LTD | Seychelles | $117.244 | $23.000 | Budget |
| 12 | EMIRATES POST COMPANY | United Arab Emirates | $116.530 | $4.000 | Budget |
| 13 | QUEEENS ENTERPRISES … | Sudan | $109.814 | $110.000 | Budget |
| 14 | MADAU KUAAC AYAI KON | Sudan | $80.630 | $13.000 | Budget |
| 15 | LUSAKA PHARMA CHEM S… | Zambia | $18.214 | $18.000 | Budget |
| 16 | LUSAKA MEDICAMP LTD | Zambia | $17.351 | $9.000 | Budget |
| 17 | HEALTH CITY CAYMAN I… | Cayman Islands | $15.300 | $8.000 | Budget |
| 18 | MINISTRY OF HEALTH | Seychelles | $13.477 | $7.000 | Budget |
| 19 | EMIRATES POST GROUP | United Arab Emirates | $5.524 | $3.000 | Budget |
| 20 | MOHAMED AHEMED MOHAMUD | Somalia | $2.000 | $2.000 | Budget |
| 21 | KALKAAL HOSPITAL | Somalia | $1.387 | $1.000 | Budget |
| 22 | FIRST CHOICE PHARMACY | Dominica | $0.014 | $0.0000 | Budget |
06
PART III — WHO’S IN THIS MARKET
Market Relationship Map
The top 20 × 20 supplier ↔ buyer network as a circular flow diagram
Fig 6.3 CIPLA LTD → MEDPRO PHARMACEUTICA PTY LTD is the strongest relationship.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left semicircle = top 20 Indian suppliers; right = top 20 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
How Indian warfarin prices vary by supplier, country and dosage form
KEY TAKEAWAY
Warfarin prices span 70732× ($0.0002 → $11.03). The coefficient of variation is 2.04. Dosage form, not destination, is the primary price driver.
S FOR SUPPLIERS
Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.
B FOR BUYERS
Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.
§7.1 Price distribution · Table 7.1
| Statistic | Value | Interpretation |
|---|---|---|
| Min | $0.0002 | Lowest observed unit price |
| P5 | $0.0070 | 5th percentile |
| P25 | $0.035 | 25th percentile (Q1) |
| Median | $0.435 | 50th percentile (Q2) |
| P75 | $0.846 | 75th percentile (Q3) |
| P95 | $6.32 | 95th percentile |
| Max | $11.03 | Highest observed unit price |
| Mean | $1.07 | Arithmetic average |
| CV | 204% | Coefficient of variation (std/mean) |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 7.1 AJANTA PHARMA LTD prices at $5.37/unit vs market median $0.435.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).
COMMODITY KINGS
high volume · low unit price
Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. CIPLA LTD Sourcing: best for cost-driven procurement.
BULK LEADERS
high volume · premium price
Branded-generic leaders, above-median pricing. e.g. AMNEAL PHARMACEUTICALS PVT Sourcing: hardest to displace; compete on relationship.
LONG-TAIL
low volume · low unit price
Spot/opportunistic players. e.g. DREAM PHARMACEUTICAL Sourcing: first to approach for new tenders.
PREMIUM NICHE
low volume · premium price
Sterile injectables and infusions. Hospital-grade. e.g. AJANTA PHARMA LTD Sourcing: expect 10× price vs tablet.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage
KEY TAKEAWAY
Extreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.
§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices
↑ TOP 10 HIGHEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Nov 2025 | AMNEAL PHARMACEU… | United States | Tablet | 175 | $2K | $11.58 | Specialty / small-batch |
| Oct 2025 | AMNEAL PHARMACEU… | United States | Tablet | 64 | $705.60 | $11.03 | Specialty / small-batch |
| Nov 2025 | AMNEAL PHARMACEU… | United States | Tablet | 234 | $3K | $10.99 | Specialty / small-batch |
| Nov 2025 | AMNEAL PHARMACEU… | United States | Tablet | 56 | $602.10 | $10.75 | Specialty / small-batch |
| Nov 2025 | AMNEAL PHARMACEU… | United States | Tablet | 56 | $602.10 | $10.75 | Specialty / small-batch |
| Nov 2025 | AMNEAL PHARMACEU… | United States | Tablet | 2K | $15K | $6.60 | Specialty / small-batch |
| Nov 2025 | AMNEAL PHARMACEU… | United States | Tablet | 2K | $15K | $6.60 | Specialty / small-batch |
| Dec 2025 | AMNEAL PHARMACEU… | United States | Tablet | 837 | $5K | $6.51 | Specialty / small-batch |
| Nov 2025 | AMNEAL PHARMACEU… | United States | Tablet | 639 | $4K | $6.29 | Specialty / small-batch |
| Nov 2025 | AMNEAL PHARMACEU… | United States | tabsusp | 1K | $8K | $5.59 | Specialty / small-batch |
↓ TOP 10 LOWEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Dec 2025 | M T MADON EXPORTS | Somalia | Tablet | 2K | $2.00 | $0.0010 | Bulk generic tablet |
| Dec 2025 | AL-SUPREME EXPORTS | Seychelles | Tablet | 30 | $0.229 | $0.0076 | Bulk generic tablet |
| Dec 2025 | DERRIC WOOD | United Arab Emirates | Tablet | 6 | $0.048 | $0.0080 | Bulk generic tablet |
| Dec 2025 | DERRIC WOOD | United Arab Emirates | Tablet | 6 | $0.049 | $0.0082 | Bulk generic tablet |
| Dec 2025 | DERRIC WOOD | United Arab Emirates | Tablet | 6 | $0.055 | $0.0092 | Bulk generic tablet |
| Dec 2025 | DERRIC WOOD | United Arab Emirates | Tablet | 6 | $0.055 | $0.0092 | Bulk generic tablet |
| Dec 2025 | AL-SUPREME EXPORTS | Seychelles | Tablet | 30 | $0.305 | $0.010 | Small sample / trial shipment |
| Oct 2025 | CIPLA LTD | Sri Lanka | Tablet | 528K | $9K | $0.016 | |
| Oct 2025 | CIPLA LTD | Sri Lanka | Tablet | 416K | $7K | $0.016 | |
| Nov 2025 | MACLEODS PHARMAC… | Chile | Tablet | 354K | $9K | $0.025 |
§7.3 Procurement cheat sheet — median USD/unit by country × dosage
Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.
NEGOTIATION RANGE
Use each cell value as the anchor price. Typical dynamics:
- Budget buyer: anchor − 10–15% (floor = cost + freight)
- Mid-market: anchor ± 5–10%
- Premium/tender: anchor + 10–25% (regulated, quality premium)
- Injection/infusion: always 4–10× the tablet price
KEY TAKEAWAYS
- Dosage form is the #1 price driver, not destination
- Light cells = easy-entry markets for small suppliers
- Dark cells = premium markets requiring regulatory investment
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Which Indian ports ship warfarin, which global ports receive it, and which corridors are high-value vs bulk
KEY TAKEAWAY
Warfarin leaves India through 7+ ports. The top 5 (MUMBAI AIR (SAHAR), MUNDRA SEA, NHAVA SHEVA SEA (JNPT)) handle 100.0% of total USD. AIR moves 68% of shipments.
S FOR SUPPLIERS
Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.
B FOR BUYERS
Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.
Fig 8.1 MUMBAI AIR (SAHAR) handles $553K — top 7 Indian origin ports by trade value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian port. Bar length = USD value. The largest ports handle the majority of trade.
Fig 8.2 Savannah is the #1 global destination port — top 25 by USD value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.
§8.1 Reference transit times for key India → global corridors
| Route | Mode | Transit time | Notes |
|---|---|---|---|
| NHAVA SHEVA SEA (JNPT) → US East Coast | Sea | 22–28 days | Via Suez; 2–3 transshipments typical |
| NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria) | Sea | 18–24 days | Direct liner service available |
| MUMBAI AIR (SAHAR) → New York JFK | Air | 3–5 days | Direct cargo; cold-chain available |
| MUNDRA SEA → Rotterdam | Sea | 20–26 days | Via Suez; Hamburg also served |
| HYDERABAD AIR → London Heathrow | Air | 2–4 days | Pharma-grade cargo corridor |
| CHENNAI SEA → Chittagong (Bangladesh) | Sea | 7–12 days | Short-sea route; high frequency |
| RAXAUL → Birgunj (Nepal) | Road | 1–2 days | Land border crossing |
| NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya) | Sea | 14–20 days | Direct or via Colombo hub |
Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Trade corridors — origin port to mode of transport to destination region
KEY TAKEAWAY
AIR dominates at 68% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.
AIR
$625K
51.3% of USD · 67.8% of ships
SEA
$594K
48.7% of USD · 32.2% of ships
Fig 8.3 The dominant corridor is MUMBAI AIR (SAHAR) → Air → Africa ($520K).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market concentration, supply-chain risk, and the dependency patterns that signal where to act
KEY TAKEAWAY
United States is the most concentrated destination (HHI 10000, 1 suppliers). Sudan is the most competitive (HHI 5000).
S FOR SUPPLIERS
The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.
B FOR BUYERS
The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.
Fig 9.1 United States (HHI 10,000) is the most concentrated — Sudan (HHI 5,000) is the most competitive.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 20 of 20 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.
§9.1 Single-source dependencies
| Buyer | Country | Sole supplier | USD | Ships | Risk |
|---|---|---|---|---|---|
| MEDPRO PHARMACEUTICA… | South Africa | CIPLA LTD | $257K | 8 | HIGH |
| AMNEAL PHARMACEUTICA… | United States | AMNEAL PHARMACEU… | $247K | 20 | HIGH |
| BREATHEFREE LANKA PV… | Sri Lanka | CIPLA LTD | $223K | 8 | HIGH |
| PHARMACARE DRUG STORE | Jordan | MACLEODS PHARMAC… | $59K | 3 | MEDIUM |
| AJANTA PHARMA PHILIP… | Philippines | AJANTA PHARMA LTD | $33K | 1 | MEDIUM |
| BREATHEFREE LANKA (P… | Sri Lanka | CIPLA LTD | $15K | 2 | MEDIUM |
| VITAFARMA S.A | Chile | MACLEODS PHARMAC… | $9K | 3 | MEDIUM |
| REPUBLIC OF NAURU - … | Nauru | HLL LIFECARE LTD | $612 | 2 | MEDIUM |
Conclusion: 20 buyers depend on exactly one Indian supplier, representing $846K in trade. For suppliers: each row is a competitor’s locked-in customer you can target.
§9.2 Multi-source resilience
| Buyer | Country | Suppliers | USD | Dominant | Resilience |
|---|
Conclusion: 0 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market entry playbook and risk landscape by destination country
KEY TAKEAWAY
15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).
§9.3 Sourcing recommendations · Table 9.1
| Country | Tier | Lead | Price | Risk | Entry approach |
|---|---|---|---|---|---|
| South Africa | Tier 3 (emerging) | 3–5 days (air) | $0.01–$0.10/unit | LOW | First-mover advantage |
| United States | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Sri Lanka | Tier 3 (emerging) | 14–28 days (sea) | $0.01–$0.10/unit | LOW | First-mover advantage |
| Jordan | Tier 3 (emerging) | 3–5 days (air) | $0.01–$0.10/unit | LOW | First-mover advantage |
| Philippines | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Chile | Tier 3 (emerging) | 3–5 days (air) | $0.01–$0.10/unit | LOW | First-mover advantage |
| Kenya | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Nigeria | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Myanmar | Tier 3 (emerging) | 3–5 days (air) | $0.01–$0.10/unit | LOW | First-mover advantage |
| Nauru | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| Australia | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| Sudan | Tier 3 (emerging) | 3–5 days (air) | $0.01–$0.10/unit | LOW | First-mover advantage |
| United Arab Emirates | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| Guyana | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| Seychelles | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.
Fig 9.2 0 markets in the Growth Opportunity zone (competitive + growing). 13 in Fragile Dependency (concentrated + shrinking).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Key markets are the top growth opportunities.
09
PART V — ACTION
Action Plan & Easy-Entry Markets
12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers
KEY TAKEAWAY
Quick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.
S
FOR SUPPLIERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A1 | Pitch top single-source buyer in South Africa | This Q | HIGH |
| A2 | Offer alternative to top multi-source buyer | This Q | HIGH |
| A3 | Audit United States lock-ins (HHI 10000) | This Q | MED |
| A5 | Enter South Africa (1 suppliers) | This Q | HIGH |
| A6 | Enter United States (1 suppliers) | This Q | MED |
| A8 | Build United States distribution | 6–12m | HIGH |
| A9 | Bundle injection/infusion catalog for premium markets | 6–12m | MED |
B
FOR BUYERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A4 | Monitor rising exporters (climbers) | This Q | MED |
| A7 | Register for South Africa tenders | 6–12m | HIGH |
| A10 | Track quarterly HHI shifts across key destinations | This Q | LOW |
| A11 | Map competitor buyer portfolios quarterly | This Q | MED |
| A12 | Qualify second source for single-source buyers | This Q | MED |
§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers
| # | Country | Region | Suppliers | Q4 USD | Growth | Barrier | Why this is easy |
|---|---|---|---|---|---|---|---|
| 1 | South Africa | Africa | 1 | $515K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 2 | United States | Other | 1 | $349K | -16.3% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 3 | Sri Lanka | Asia | 1 | $238K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 4 | Jordan | Other | 1 | $59K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 5 | Philippines | Asia | 1 | $33K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 6 | Chile | Other | 1 | $9K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 7 | Kenya | Africa | 2 | $6K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 8 | Nigeria | Africa | 1 | $5K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 9 | Myanmar | Asia | 2 | $4K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 10 | Nauru | Other | 1 | $612 | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 11 | Australia | Other | 1 | $329 | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 12 | Sudan | Africa | 2 | $217 | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 13 | United Arab Emirates | Other | 3 | $149 | 0% | LOW | Low competition (3 suppliers), accessible market |
| 14 | Guyana | Other | 1 | $133 | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 15 | Seychelles | Africa | 3 | $131 | 0% | LOW | Low competition (3 suppliers), accessible market |
This report covers 143 2025-Q4 Warfarin shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/warfarin
10
PART VI — EVIDENCE REGISTER
Comprehensive Shipment Records by Region
Authoritative source behind all analytics in this report — every shipment appears exactly once
KEY TAKEAWAY
This section contains every one of the 143 2025-Q4 warfarin shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.
S FOR SUPPLIERS
Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.
B FOR BUYERS
Jump to your country to see every Indian warfarin shipment that arrived in 2025-Q4: supplier, price, dosage, port.
§10.1 Global totals
SHIPMENTS
143
across all regions
TOTAL USD
$1.22M
2025-Q4 FOB value
UNITS
27.6M
tablets, capsules, etc.
SUPPLIERS
25
Indian exporters
BUYERS
24
global importers
COUNTRIES
21
destinations
§10.2 Regional breakdown
§10.3 Key insights from the data
Africa is the largest region at $526K (43.1%), spanning 7 countries.
25 Indian suppliers shipped to 24 buyers across 21 countries — average shipment value $9K.
Top 0 markets: .
Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.
§10.4 How to read a country page
1
6 KPI cards — shipments, USD, qty, exporters, importers, avg unit price.
2
4 mini-lists — top exporters, importers, dosages, monthly trend.
3
Shipment register — every row grouped by exporter. No row is duplicated or omitted.
10
PART VI — DRILL-DOWN · AFRICA
Region: Africa
7 countries · 40 shipments · $526K · 11 Indian suppliers · 12 buyers
SHIPMENTS
40
USD
$526K
COUNTRIES
7
SUPPLIERS
11
BUYERS
12
HHI
9,594
concentrated
Top 7 destination countries in Africa
1
South Africa (97.9%)
$515K
2
Kenya (1.1%)
$6K
3
Nigeria (0.9%)
$5K
4
Sudan (0.0%)
$217.47
5
Seychelles (0.0%)
$130.72
6
Zambia (0.0%)
$35.57
7
Somalia (0.0%)
$3.39
Top 11 Indian suppliers into Africa
1
CIPLA LTD
$515K
2
NAMAN PHARMA DRUGS
$5K
3
CARIESCO EXPORTS
$5K
4
AFRO LIFESCIENCE
$501.36
5
JYOTI IMPEX
$116.71
6
BAKER & DAVIS PVT LTD
$109.81
7
MEDICOS LIFESCIENCES
$35.57
8
HLL LIFECARE LTD
$13.48
9
M T MADON EXPORTS
$2.00
10
CURE EARTH PHARMA
$1.39
11
AL-SUPREME EXPORTS
$0.534
Top 10 Africa importers
1
MEDPRO PHARMACEUTICA PTY LTD · South Africa
$257K
2
CYERDITTRADING CO LTD · Kenya
$393.71
3
GOOD HEALTH (PTY) LTD · Seychelles
$117.24
4
QUEEENS ENTERPRISES CO LTD · Sudan
$109.81
5
MADAU KUAAC AYAI KON · Sudan
$80.63
6
LUSAKA PHARMA CHEM SUPPLIES LTD · Zambia
$18.21
7
LUSAKA MEDICAMP LTD · Zambia
$17.35
8
MINISTRY OF HEALTH · Seychelles
$13.48
9
MOHAMED AHEMED MOHAMUD · Somalia
$2.00
10
KALKAAL HOSPITAL · Somalia
$1.39
Top 2 dosage forms
1
Tablet
$526K
2
Unknown
$60.03
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 4 | $5K | $1K |
| Nov | 30 | $515K | $17K |
| Dec | 6 | $6K | $951.08 |
Shipment register · 40 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — CIPLA LTD · 16 shipments · $515K | |||||||||||
| 1 | Nov 2025 | MEDPRO PHARMACEUTICA PTY LTD | South Africa | Tablet | 956.6K | NOS | $0.035 | $34K | MUMBAI AIR (SAHAR) | CAPE TOWN | AIR |
| 2 | Nov 2025 | MEDPRO PHARMACEUTICA PTY LTD | South Africa | Tablet | 940.0K | NOS | $0.035 | $33K | MUMBAI AIR (SAHAR) | CAPE TOWN | AIR |
| 3 | Nov 2025 | MEDPRO PHARMACEUTICA PTY LTD | South Africa | Tablet | 941.6K | NOS | $0.035 | $33K | MUMBAI AIR (SAHAR) | CAPE TOWN | AIR |
| 4 | Nov 2025 | MEDPRO PHARMACEUTICA PTY LTD | South Africa | Tablet | 945.2K | NOS | $0.035 | $33K | MUMBAI AIR (SAHAR) | CAPE TOWN | AIR |
| 5 | Nov 2025 | UNKNOWN BUYER | South Africa | Tablet | 956.6K | NOS | $0.035 | $34K | MUMBAI AIR (SAHAR) | CAPE TOWN | AIR |
| 6 | Nov 2025 | UNKNOWN BUYER | South Africa | Tablet | 940.0K | NOS | $0.035 | $33K | MUMBAI AIR (SAHAR) | CAPE TOWN | AIR |
| 7 | Nov 2025 | UNKNOWN BUYER | South Africa | Tablet | 941.6K | NOS | $0.035 | $33K | MUMBAI AIR (SAHAR) | CAPE TOWN | AIR |
| 8 | Nov 2025 | UNKNOWN BUYER | South Africa | Tablet | 945.2K | NOS | $0.035 | $33K | MUMBAI AIR (SAHAR) | CAPE TOWN | AIR |
| 9 | Nov 2025 | MEDPRO PHARMACEUTICA PTY LTD | South Africa | Tablet | 940.0K | NOS | $0.033 | $31K | MUMBAI AIR (SAHAR) | JOHANNESBURG - JOHAN | AIR |
| 10 | Nov 2025 | MEDPRO PHARMACEUTICA PTY LTD | South Africa | Tablet | 941.6K | NOS | $0.033 | $31K | MUMBAI AIR (SAHAR) | JOHANNESBURG - JOHAN | AIR |
| 11 | Nov 2025 | MEDPRO PHARMACEUTICA PTY LTD | South Africa | Tablet | 945.2K | NOS | $0.033 | $31K | MUMBAI AIR (SAHAR) | JOHANNESBURG - JOHAN | AIR |
| 12 | Nov 2025 | MEDPRO PHARMACEUTICA PTY LTD | South Africa | Tablet | 956.6K | NOS | $0.033 | $32K | MUMBAI AIR (SAHAR) | JOHANNESBURG - JOHAN | AIR |
| 13 | Nov 2025 | UNKNOWN BUYER | South Africa | Tablet | 940.0K | NOS | $0.033 | $31K | MUMBAI AIR (SAHAR) | JOHANNESBURG - JOHAN | AIR |
| 14 | Nov 2025 | UNKNOWN BUYER | South Africa | Tablet | 941.6K | NOS | $0.033 | $31K | MUMBAI AIR (SAHAR) | JOHANNESBURG - JOHAN | AIR |
| 15 | Nov 2025 | UNKNOWN BUYER | South Africa | Tablet | 945.2K | NOS | $0.033 | $31K | MUMBAI AIR (SAHAR) | JOHANNESBURG - JOHAN | AIR |
| 16 | Nov 2025 | UNKNOWN BUYER | South Africa | Tablet | 956.6K | NOS | $0.033 | $32K | MUMBAI AIR (SAHAR) | JOHANNESBURG - JOHAN | AIR |
| SUPPLIER #2 — NAMAN PHARMA DRUGS · 1 shipments · $5K | |||||||||||
| 17 | Dec 2025 | UNKNOWN BUYER | Kenya | Tablet | 1.0K | NOS | $5.29 | $5K | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
| SUPPLIER #3 — CARIESCO EXPORTS · 1 shipments · $5K | |||||||||||
| 18 | Oct 2025 | UNLISTED BUYER | Nigeria | Tablet | 1.7K | NOS | $2.87 | $5K | NHAVA SHEVA SEA (JNPT) | Apapa | SEA |
| SUPPLIER #4 — AFRO LIFESCIENCE · 9 shipments · $501.36 | |||||||||||
| 19 | Nov 2025 | MADAU KUAAC AYAI KON | Sudan | Tablet | 200 | PCS | $0.062 | $12.37 | MUMBAI AIR (SAHAR) | JUMLA | AIR |
| 20 | Nov 2025 | MADAU KUAAC AYAI KON | Sudan | Tablet | 200 | PCS | $0.071 | $14.22 | MUMBAI AIR (SAHAR) | JUMLA | AIR |
| 21 | Nov 2025 | MADAU KUAAC AYAI KON | Sudan | Tablet | 200 | PCS | $0.063 | $12.57 | MUMBAI AIR (SAHAR) | JUMLA | AIR |
| 22 | Nov 2025 | MADAU KUAAC AYAI KON | Sudan | Tablet | 200 | PCS | $0.072 | $14.45 | MUMBAI AIR (SAHAR) | JUMLA | AIR |
| 23 | Nov 2025 | UNKNOWN BUYER | Sudan | Tablet | 200 | PCS | $0.063 | $12.57 | MUMBAI AIR (SAHAR) | JUMLA | AIR |
| 24 | Nov 2025 | UNKNOWN BUYER | Sudan | Tablet | 200 | PCS | $0.072 | $14.45 | MUMBAI AIR (SAHAR) | JUMLA | AIR |
| 25 | Nov 2025 | MADAU KUAAC AYAI KON | Sudan | Tablet | 200 | PCS | $0.063 | $12.57 | MUMBAI AIR (SAHAR) | JUMLA | AIR |
| 26 | Nov 2025 | MADAU KUAAC AYAI KON | Sudan | Tablet | 200 | PCS | $0.072 | $14.45 | MUMBAI AIR (SAHAR) | JUMLA | AIR |
| 27 | Dec 2025 | CYERDITTRADING CO LTD | Kenya | Tablet | 5.0K | PCS | $0.079 | $393.71 | NHAVA SHEVA SEA (JNPT) | Mombasa | SEA |
| SUPPLIER #5 — JYOTI IMPEX · 3 shipments · $116.71 | |||||||||||
| 28 | Nov 2025 | GOOD HEALTH (PTY) LTD | Seychelles | Tablet | 50 | NOS | $1.13 | $56.68 | MUMBAI AIR (SAHAR) | MAHE ISLAND | AIR |
| 29 | Nov 2025 | GOOD HEALTH (PTY) LTD | Seychelles | 30 | NOS | $1.13 | $33.97 | MUMBAI AIR (SAHAR) | MAHE ISLAND | AIR | |
| 30 | Nov 2025 | GOOD HEALTH (PTY) LTD | Seychelles | 20 | NOS | $1.30 | $26.06 | MUMBAI AIR (SAHAR) | MAHE ISLAND | AIR | |
| SUPPLIER #6 — BAKER & DAVIS PVT LTD · 1 shipments · $109.81 | |||||||||||
| 31 | Nov 2025 | QUEEENS ENTERPRISES CO LTD | Sudan | Tablet | 1.0K | NOS | $0.110 | $109.81 | MUMBAI AIR (SAHAR) | JUMLA | AIR |
| SUPPLIER #7 — MEDICOS LIFESCIENCES · 3 shipments · $35.57 | |||||||||||
| 32 | Oct 2025 | LUSAKA MEDICAMP LTD | Zambia | Tablet | 100 | NOS | $0.087 | $8.68 | AHMEDABAD AIR | LUSAKA | AIR |
| 33 | Oct 2025 | LUSAKA MEDICAMP LTD | Zambia | Tablet | 100 | NOS | $0.087 | $8.68 | AHMEDABAD AIR | LUSAKA | AIR |
| 34 | Dec 2025 | LUSAKA PHARMA CHEM SUPPLIES LTD | Zambia | Tablet | 200 | NOS | $0.091 | $18.21 | AHMEDABAD AIR | LUSAKA | AIR |
| SUPPLIER #8 — HLL LIFECARE LTD · 2 shipments · $13.48 | |||||||||||
| 35 | Nov 2025 | MINISTRY OF HEALTH | Seychelles | Tablet | 12.0K | NOS | $0.0010 | $11.98 | DELHI AIR | MAHE ISLAND | AIR |
| 36 | Nov 2025 | MINISTRY OF HEALTH | Seychelles | Tablet | 1.5K | NOS | $0.0010 | $1.50 | DELHI AIR | MAHE ISLAND | AIR |
| SUPPLIER #9 — M T MADON EXPORTS · 1 shipments · $2.00 | |||||||||||
| 37 | Dec 2025 | MOHAMED AHEMED MOHAMUD | Somalia | Tablet | 2.0K | NOS | $0.0010 | $2.00 | MUMBAI AIR (SAHAR) | HARGEISA | AIR |
| SUPPLIER #10 — CURE EARTH PHARMA · 1 shipments · $1.39 | |||||||||||
| 38 | Oct 2025 | KALKAAL HOSPITAL | Somalia | Tablet | 10 | NOS | $0.139 | $1.39 | CHENNAI AIR | MOGADISCHU | AIR |
| SUPPLIER #11 — AL-SUPREME EXPORTS · 2 shipments · $0.534 | |||||||||||
| 39 | Dec 2025 | GOOD HEALTH (PTY) LTD | Seychelles | Tablet | 30 | NOS | $0.0076 | $0.229 | CHENNAI AIR | MAHE ISLAND | AIR |
| 40 | Dec 2025 | GOOD HEALTH (PTY) LTD | Seychelles | Tablet | 30 | NOS | $0.010 | $0.305 | CHENNAI AIR | MAHE ISLAND | AIR |
10
PART VI — DRILL-DOWN · ASIA
Region: Asia
5 countries · 55 shipments · $335K · 8 Indian suppliers · 8 buyers
SHIPMENTS
55
USD
$335K
COUNTRIES
5
SUPPLIERS
8
BUYERS
8
HHI
5,482
concentrated
Top 5 destination countries in Asia
1
Sri Lanka (71.2%)
$238K
2
Jordan (17.7%)
$59K
3
Philippines (9.7%)
$33K
4
Myanmar (1.3%)
$4K
5
United Arab Emirates (0.0%)
$148.59
Top 8 Indian suppliers into Asia
1
CIPLA LTD
$238K
2
MACLEODS PHARMACEUTICALS LTD
$59K
3
AJANTA PHARMA LTD
$33K
4
DREAM PHARMACEUTICAL
$2K
5
SCOTT EDIL PHARMACIA LTD
$2K
6
DERRIC WOOD
$143.06
7
MOVID IMPEX
$2.91
8
PREMIER ENTERPRISE
$2.61
Top 6 Asia importers
1
BREATHEFREE LANKA PVT LTD · Sri Lanka
$223K
2
PHARMACARE DRUG STORE · Jordan
$59K
3
AJANTA PHARMA PHILIPPINES INC · Philippines
$33K
4
BREATHEFREE LANKA (PVT) LTD · Sri Lanka
$15K
5
EMIRATES POST COMPANY · United Arab Emirates
$116.53
6
EMIRATES POST GROUP · United Arab Emirates
$5.52
Top 1 dosage forms
1
Tablet
$335K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 2 | $15K | $8K |
| Nov | 38 | $256K | $7K |
| Dec | 15 | $64K | $4K |
Shipment register · 55 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — CIPLA LTD · 10 shipments · $238K | |||||||||||
| 1 | Oct 2025 | BREATHEFREE LANKA (PVT) LTD | Sri Lanka | Tablet | 528.0K | NOS | $0.016 | $9K | NHAVA SHEVA SEA (JNPT) | Colombo | SEA |
| 2 | Oct 2025 | BREATHEFREE LANKA (PVT) LTD | Sri Lanka | Tablet | 416.0K | NOS | $0.016 | $7K | NHAVA SHEVA SEA (JNPT) | Colombo | SEA |
| 3 | Nov 2025 | BREATHEFREE LANKA PVT LTD | Sri Lanka | Tablet | 950.0K | NOS | $0.029 | $28K | NHAVA SHEVA SEA (JNPT) | Colombo | SEA |
| 4 | Nov 2025 | BREATHEFREE LANKA PVT LTD | Sri Lanka | Tablet | 950.0K | NOS | $0.029 | $28K | NHAVA SHEVA SEA (JNPT) | Colombo | SEA |
| 5 | Nov 2025 | BREATHEFREE LANKA PVT LTD | Sri Lanka | Tablet | 956.0K | NOS | $0.029 | $28K | NHAVA SHEVA SEA (JNPT) | Colombo | SEA |
| 6 | Nov 2025 | BREATHEFREE LANKA PVT LTD | Sri Lanka | Tablet | 960.0K | NOS | $0.029 | $28K | NHAVA SHEVA SEA (JNPT) | Colombo | SEA |
| 7 | Nov 2025 | BREATHEFREE LANKA PVT LTD | Sri Lanka | Tablet | 960.0K | NOS | $0.029 | $28K | NHAVA SHEVA SEA (JNPT) | Colombo | SEA |
| 8 | Nov 2025 | BREATHEFREE LANKA PVT LTD | Sri Lanka | Tablet | 959.0K | NOS | $0.029 | $28K | NHAVA SHEVA SEA (JNPT) | Colombo | SEA |
| 9 | Nov 2025 | BREATHEFREE LANKA PVT LTD | Sri Lanka | Tablet | 956.0K | NOS | $0.029 | $28K | NHAVA SHEVA SEA (JNPT) | Colombo | SEA |
| 10 | Nov 2025 | BREATHEFREE LANKA PVT LTD | Sri Lanka | Tablet | 953.0K | NOS | $0.029 | $28K | NHAVA SHEVA SEA (JNPT) | Colombo | SEA |
| SUPPLIER #2 — MACLEODS PHARMACEUTICALS LTD · 3 shipments · $59K | |||||||||||
| 11 | Dec 2025 | PHARMACARE DRUG STORE | Jordan | Tablet | 1.4M | NOS | $0.040 | $57K | DELHI AIR | AMMAN | AIR |
| 12 | Dec 2025 | PHARMACARE DRUG STORE | Jordan | Tablet | 52.6K | NOS | $0.040 | $2K | DELHI AIR | AMMAN | AIR |
| 13 | Dec 2025 | PHARMACARE DRUG STORE | Jordan | Tablet | 218.3K | NOS | $0.0000 | $0.106 | DELHI AIR | AMMAN | AIR |
| SUPPLIER #3 — AJANTA PHARMA LTD · 1 shipments · $33K | |||||||||||
| 14 | Nov 2025 | AJANTA PHARMA PHILIPPINES INC | Philippines | Tablet | 6.1K | NOS | $5.37 | $33K | MUMBAI AIR (SAHAR) | MANILA | AIR |
| SUPPLIER #4 — DREAM PHARMACEUTICAL · 1 shipments · $2K | |||||||||||
| 15 | Dec 2025 | UNLISTED BUYER | Myanmar | Tablet | 30.0K | NOS | $0.080 | $2K | AHMEDABAD AIR | YANGON | AIR |
| SUPPLIER #5 — SCOTT EDIL PHARMACIA LTD · 1 shipments · $2K | |||||||||||
| 16 | Dec 2025 | UNLISTED BUYER | Myanmar | Tablet | 20.0K | NOS | $0.103 | $2K | NHAVA SHEVA SEA (JNPT) | Yangon | SEA |
| SUPPLIER #6 — DERRIC WOOD · 37 shipments · $143.06 | |||||||||||
| 17 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 2 | PCS | $0.846 | $1.69 | DELHI AIR | DUBAI | AIR |
| 18 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 6 | PCS | $0.823 | $4.94 | DELHI AIR | DUBAI | AIR |
| 19 | Nov 2025 | UNKNOWN BUYER | United Arab Emirates | Tablet | 2 | PCS | $0.846 | $1.69 | DELHI AIR | DUBAI | AIR |
| 20 | Nov 2025 | UNKNOWN BUYER | United Arab Emirates | Tablet | 6 | PCS | $0.823 | $4.94 | DELHI AIR | DUBAI | AIR |
| 21 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 2 | PCS | $0.846 | $1.69 | DELHI AIR | DUBAI | AIR |
| 22 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 6 | PCS | $0.823 | $4.94 | DELHI AIR | DUBAI | AIR |
| 23 | Nov 2025 | UNKNOWN BUYER | United Arab Emirates | Tablet | 2 | PCS | $0.846 | $1.69 | DELHI AIR | DUBAI | AIR |
| 24 | Nov 2025 | UNKNOWN BUYER | United Arab Emirates | Tablet | 6 | PCS | $0.823 | $4.94 | DELHI AIR | DUBAI | AIR |
| 25 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 2 | PCS | $0.846 | $1.69 | DELHI AIR | DUBAI | AIR |
| 26 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 6 | PCS | $0.823 | $4.94 | DELHI AIR | DUBAI | AIR |
| 27 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 2 | PCS | $0.846 | $1.69 | DELHI AIR | DUBAI | AIR |
| 28 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 6 | PCS | $0.823 | $4.94 | DELHI AIR | DUBAI | AIR |
| 29 | Nov 2025 | UNKNOWN BUYER | United Arab Emirates | Tablet | 2 | PCS | $0.846 | $1.69 | DELHI AIR | DUBAI | AIR |
| 30 | Nov 2025 | UNKNOWN BUYER | United Arab Emirates | Tablet | 6 | PCS | $0.823 | $4.94 | DELHI AIR | DUBAI | AIR |
| 31 | Nov 2025 | UNKNOWN BUYER | United Arab Emirates | Tablet | 2 | PCS | $0.846 | $1.69 | DELHI AIR | DUBAI | AIR |
| 32 | Nov 2025 | UNKNOWN BUYER | United Arab Emirates | Tablet | 6 | PCS | $0.823 | $4.94 | DELHI AIR | DUBAI | AIR |
| 33 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 6 | PCS | $0.837 | $5.02 | DELHI AIR | DUBAI | AIR |
| 34 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 6 | PCS | $0.994 | $5.96 | DELHI AIR | DUBAI | AIR |
| 35 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 9 | PCS | $0.815 | $7.34 | DELHI AIR | DUBAI | AIR |
| 36 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 6 | PCS | $0.848 | $5.09 | DELHI AIR | DUBAI | AIR |
| 37 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 6 | PCS | $0.993 | $5.96 | DELHI AIR | DUBAI | AIR |
| 38 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 6 | PCS | $0.826 | $4.95 | DELHI AIR | DUBAI | AIR |
| 39 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 6 | PCS | $0.847 | $5.08 | DELHI AIR | DUBAI | AIR |
| 40 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 6 | PCS | $0.993 | $5.96 | DELHI AIR | DUBAI | AIR |
| 41 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 6 | PCS | $0.853 | $5.12 | DELHI AIR | DUBAI | AIR |
| 42 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 6 | PCS | $1.000 | $6.00 | DELHI AIR | DUBAI | AIR |
| 43 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 6 | PCS | $0.831 | $4.99 | DELHI AIR | DUBAI | AIR |
| 44 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 6 | PCS | $0.831 | $4.99 | DELHI AIR | DUBAI | AIR |
| 45 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 6 | PCS | $0.829 | $4.98 | DELHI AIR | DUBAI | AIR |
| 46 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 6 | PCS | $0.852 | $5.11 | DELHI AIR | DUBAI | AIR |
| 47 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 6 | PCS | $0.830 | $4.98 | DELHI AIR | DUBAI | AIR |
| 48 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 6 | PCS | $0.0092 | $0.055 | DELHI AIR | DUBAI | AIR |
| 49 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 6 | PCS | $0.0082 | $0.049 | DELHI AIR | DUBAI | AIR |
| 50 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 6 | PCS | $0.0092 | $0.055 | DELHI AIR | DUBAI | AIR |
| 51 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 6 | PCS | $0.0080 | $0.048 | DELHI AIR | DUBAI | AIR |
| 52 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 6 | PCS | $0.961 | $5.77 | DELHI AIR | DUBAI | AIR |
| 53 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 3 | PCS | $0.834 | $2.50 | DELHI AIR | DUBAI | AIR |
| SUPPLIER #7 — MOVID IMPEX · 1 shipments · $2.91 | |||||||||||
| 54 | Dec 2025 | EMIRATES POST GROUP | United Arab Emirates | Tablet | 4 | NOS | $0.728 | $2.91 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| SUPPLIER #8 — PREMIER ENTERPRISE · 1 shipments · $2.61 | |||||||||||
| 55 | Nov 2025 | EMIRATES POST GROUP | United Arab Emirates | Tablet | 6 | NOS | $0.435 | $2.61 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
10
PART VI — DRILL-DOWN · AMERICAS
Region: Americas
7 countries · 41 shipments · $358K · 7 Indian suppliers · 6 buyers
SHIPMENTS
41
USD
$358K
COUNTRIES
7
SUPPLIERS
7
BUYERS
6
HHI
9,474
concentrated
Top 7 destination countries in Americas
1
United States (97.3%)
$349K
2
Chile (2.7%)
$9K
3
Guyana (0.0%)
$133.37
4
Ecuador (0.0%)
$15.60
5
Cayman Islands (0.0%)
$15.30
6
Saint Lucia (0.0%)
$8.72
7
Dominica (0.0%)
$0.014
Top 7 Indian suppliers into Americas
1
AMNEAL PHARMACEUTICALS PVT LTD
$349K
2
MACLEODS PHARMACEUTICALS LTD
$9K
3
PEAK HEALTHCARE
$133.37
4
SUBHRA PHARMA PRIAVATE LTD
$15.60
5
NARAYANA HRUDAYALAYA LTD
$15.30
6
NAMAN GLOBAL IMPEX PVT LTD
$8.72
7
AASHIRWAD PHARMA INTERNATIONAL PVT LTD
$0.014
Top 4 Americas importers
1
AMNEAL PHARMACEUTICALS LLC · United States
$247K
2
VITAFARMA S.A · Chile
$9K
3
HEALTH CITY CAYMAN ISLANDS (HCCI) · Cayman Islands
$15.30
4
FIRST CHOICE PHARMACY · Dominica
$0.014
Top 2 dosage forms
1
Tablet
$341K
2
tabsusp
$17K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 2 | $20K | $10K |
| Nov | 22 | $320K | $15K |
| Dec | 17 | $18K | $1K |
Shipment register · 41 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — AMNEAL PHARMACEUTICALS PVT LTD · 26 shipments · $349K | |||||||||||
| 1 | Oct 2025 | AMNEAL PHARMACEUTICALS LLC | United States | Tablet | 64 | NOS | $11.03 | $705.60 | MUNDRA SEA | SAVANNAH | SEA |
| 2 | Oct 2025 | AMNEAL PHARMACEUTICALS LLC | United States | Tablet | 16.4K | NOS | $1.20 | $20K | MUNDRA SEA | SAVANNAH | SEA |
| 3 | Nov 2025 | AMNEAL PHARMACEUTICALS LLC | United States | Tablet | 31.8K | NOS | $0.673 | $21K | MUNDRA SEA | Savannah | SEA |
| 4 | Nov 2025 | AMNEAL PHARMACEUTICALS LLC | United States | Tablet | 23.1K | NOS | $0.742 | $17K | MUNDRA SEA | Savannah | SEA |
| 5 | Nov 2025 | AMNEAL PHARMACEUTICALS LLC | United States | Tablet | 16.8K | NOS | $0.762 | $13K | MUNDRA SEA | Savannah | SEA |
| 6 | Nov 2025 | AMNEAL PHARMACEUTICALS LLC | United States | Tablet | 639 | NOS | $6.29 | $4K | MUNDRA SEA | Savannah | SEA |
| 7 | Nov 2025 | AMNEAL PHARMACEUTICALS LLC | United States | Tablet | 23.3K | NOS | $0.782 | $18K | MUNDRA SEA | Savannah | SEA |
| 8 | Nov 2025 | AMNEAL PHARMACEUTICALS LLC | United States | tabsusp | 1.4K | NOS | $5.59 | $8K | MUNDRA SEA | Savannah | SEA |
| 9 | Nov 2025 | AMNEAL PHARMACEUTICALS LLC | United States | tabsusp | 11.5K | NOS | $0.769 | $9K | MUNDRA SEA | Savannah | SEA |
| 10 | Nov 2025 | AMNEAL PHARMACEUTICALS LLC | United States | Tablet | 70.0K | NOS | $0.789 | $55K | MUNDRA SEA | Savannah | SEA |
| 11 | Nov 2025 | AMNEAL PHARMACEUTICALS LLC | United States | Tablet | 2.3K | NOS | $6.60 | $15K | MUNDRA SEA | Savannah | SEA |
| 12 | Nov 2025 | UNKNOWN BUYER | United States | Tablet | 1.4K | NOS | $5.59 | $8K | MUNDRA SEA | Savannah | SEA |
| 13 | Nov 2025 | UNKNOWN BUYER | United States | Tablet | 11.5K | NOS | $0.769 | $9K | MUNDRA SEA | Savannah | SEA |
| 14 | Nov 2025 | UNKNOWN BUYER | United States | Tablet | 70.0K | NOS | $0.789 | $55K | MUNDRA SEA | Savannah | SEA |
| 15 | Nov 2025 | UNKNOWN BUYER | United States | Tablet | 2.3K | NOS | $6.60 | $15K | MUNDRA SEA | Savannah | SEA |
| 16 | Nov 2025 | AMNEAL PHARMACEUTICALS LLC | United States | Tablet | 10.9K | NOS | $1.24 | $13K | MUNDRA SEA | Savannah | SEA |
| 17 | Nov 2025 | AMNEAL PHARMACEUTICALS LLC | United States | Tablet | 56 | NOS | $10.75 | $602.10 | MUNDRA SEA | Savannah | SEA |
| 18 | Nov 2025 | UNKNOWN BUYER | United States | Tablet | 10.9K | NOS | $1.24 | $13K | MUNDRA SEA | Savannah | SEA |
| 19 | Nov 2025 | UNKNOWN BUYER | United States | Tablet | 56 | NOS | $10.75 | $602.10 | MUNDRA SEA | Savannah | SEA |
| 20 | Nov 2025 | AMNEAL PHARMACEUTICALS LLC | United States | Tablet | 9.6K | NOS | $1.27 | $12K | MUNDRA SEA | Savannah | SEA |
| 21 | Nov 2025 | AMNEAL PHARMACEUTICALS LLC | United States | Tablet | 175 | NOS | $11.58 | $2K | MUNDRA SEA | Savannah | SEA |
| 22 | Nov 2025 | AMNEAL PHARMACEUTICALS LLC | United States | Tablet | 14.7K | NOS | $1.20 | $18K | MUNDRA SEA | Savannah | SEA |
| 23 | Nov 2025 | AMNEAL PHARMACEUTICALS LLC | United States | Tablet | 234 | NOS | $10.99 | $3K | MUNDRA SEA | Savannah | SEA |
| 24 | Dec 2025 | AMNEAL PHARMACEUTICALS LLC | United States | Tablet | 3.1K | NOS | $0.796 | $3K | MUNDRA SEA | Savannah | SEA |
| 25 | Dec 2025 | AMNEAL PHARMACEUTICALS LLC | United States | Tablet | 837 | NOS | $6.51 | $5K | MUNDRA SEA | Savannah | SEA |
| 26 | Dec 2025 | AMNEAL PHARMACEUTICALS LLC | United States | Tablet | 11.5K | NOS | $0.796 | $9K | MUNDRA SEA | Savannah | SEA |
| SUPPLIER #2 — MACLEODS PHARMACEUTICALS LTD · 3 shipments · $9K | |||||||||||
| 27 | Nov 2025 | VITAFARMA S.A | Chile | Tablet | 354.0K | NOS | $0.025 | $9K | DELHI AIR | SANTIAGO DE CHILE - | AIR |
| 28 | Dec 2025 | VITAFARMA S.A | Chile | Tablet | 673.8K | NOS | $0.0004 | $284.12 | NHAVA SHEVA SEA (JNPT) | San Antonio | AIR |
| 29 | Dec 2025 | VITAFARMA S.A | Chile | Tablet | 675.0K | NOS | $0.0004 | $284.62 | NHAVA SHEVA SEA (JNPT) | San Antonio | AIR |
| SUPPLIER #3 — PEAK HEALTHCARE · 6 shipments · $133.37 | |||||||||||
| 30 | Dec 2025 | UNLISTED BUYER | Guyana | Tablet | 7 | NOS | $0.683 | $4.78 | NHAVA SHEVA SEA (JNPT) | Georgetown | SEA |
| 31 | Dec 2025 | UNLISTED BUYER | Guyana | Tablet | 67 | NOS | $0.924 | $61.93 | NHAVA SHEVA SEA (JNPT) | Georgetown | SEA |
| 32 | Dec 2025 | UNLISTED BUYER | Guyana | Tablet | 7 | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Georgetown | SEA |
| 33 | Dec 2025 | UNLISTED BUYER | Guyana | Tablet | 67 | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Georgetown | SEA |
| 34 | Dec 2025 | UNLISTED BUYER | Guyana | Tablet | 7 | NOS | $0.682 | $4.77 | NHAVA SHEVA SEA (JNPT) | Georgetown | SEA |
| 35 | Dec 2025 | UNLISTED BUYER | Guyana | Tablet | 67 | NOS | $0.924 | $61.89 | NHAVA SHEVA SEA (JNPT) | Georgetown | SEA |
| SUPPLIER #4 — SUBHRA PHARMA PRIAVATE LTD · 1 shipments · $15.60 | |||||||||||
| 36 | Dec 2025 | UNLISTED BUYER | Ecuador | Tablet | 100.1K | NOS | $0.0002 | $15.60 | MUMBAI AIR (SAHAR) | QUITO | SEA |
| SUPPLIER #5 — NARAYANA HRUDAYALAYA LTD · 2 shipments · $15.30 | |||||||||||
| 37 | Dec 2025 | HEALTH CITY CAYMAN ISLANDS (HCCI) | Cayman Islands | Tablet | 30 | NOS | $0.102 | $3.06 | BANGALORE AIR | GEORGETOWN | AIR |
| 38 | Dec 2025 | HEALTH CITY CAYMAN ISLANDS (HCCI) | Cayman Islands | Tablet | 120 | NOS | $0.102 | $12.24 | BANGALORE AIR | GEORGETOWN | AIR |
| SUPPLIER #6 — NAMAN GLOBAL IMPEX PVT LTD · 2 shipments · $8.72 | |||||||||||
| 39 | Dec 2025 | UNKNOWN BUYER | Saint Lucia | Tablet | 20 | NOS | $0.085 | $1.69 | MUMBAI AIR (SAHAR) | ST LUCIA | AIR |
| 40 | Dec 2025 | UNKNOWN BUYER | Saint Lucia | Tablet | 60 | NOS | $0.117 | $7.03 | MUMBAI AIR (SAHAR) | ST LUCIA | AIR |
| SUPPLIER #7 — AASHIRWAD PHARMA INTERNATIONAL PVT LTD · 1 shipments · $0.014 | |||||||||||
| 41 | Dec 2025 | FIRST CHOICE PHARMACY | Dominica | Tablet | 15 | NOS | $0.0009 | $0.014 | MUMBAI AIR (SAHAR) | YEOSU | AIR |
10
PART VI — DRILL-DOWN · OCEANIA
Region: Oceania
2 countries · 7 shipments · $940.95 · 2 Indian suppliers · 3 buyers
SHIPMENTS
7
USD
$940.95
COUNTRIES
2
SUPPLIERS
2
BUYERS
3
HHI
5,452
concentrated
Top 2 destination countries in Oceania
1
Nauru (65.0%)
$611.96
2
Australia (35.0%)
$328.99
Top 2 Indian suppliers into Oceania
1
HLL LIFECARE LTD
$611.96
2
SYNERGY TRADING
$328.99
Top 2 Oceania importers
1
REPUBLIC OF NAURU - DEPARTMENT OF H · Nauru
$611.96
2
REPUBLIC OF NAURU, DEPARTMENT OF · Australia
$236.04
Top 1 dosage forms
1
Tablet
$940.95
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 5 | $328.99 | $65.80 |
| Dec | 2 | $611.96 | $305.98 |
Shipment register · 7 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — HLL LIFECARE LTD · 2 shipments · $611.96 | |||||||||||
| 1 | Dec 2025 | REPUBLIC OF NAURU - DEPARTMENT OF H | Nauru | Tablet | 1.6K | NOS | $0.204 | $326.38 | DELHI AIR | NAURU ISLAND | AIR |
| 2 | Dec 2025 | REPUBLIC OF NAURU - DEPARTMENT OF H | Nauru | Tablet | 1.4K | NOS | $0.204 | $285.58 | DELHI AIR | NAURU ISLAND | AIR |
| SUPPLIER #2 — SYNERGY TRADING · 5 shipments · $328.99 | |||||||||||
| 3 | Nov 2025 | REPUBLIC OF NAURU, DEPARTMENT OF | Australia | Tablet | 500 | NOS | $0.184 | $91.80 | MUMBAI AIR (SAHAR) | BRISBANE | AIR |
| 4 | Nov 2025 | REPUBLIC OF NAURU, DEPARTMENT OF | Australia | Tablet | 500 | NOS | $0.186 | $92.96 | MUMBAI AIR (SAHAR) | BRISBANE | AIR |
| 5 | Nov 2025 | UNKNOWN BUYER | Australia | Tablet | 500 | NOS | $0.186 | $92.96 | MUMBAI AIR (SAHAR) | BRISBANE | AIR |
| 6 | Nov 2025 | REPUBLIC OF NAURU, DEPARTMENT OF | Australia | Tablet | 200 | NOS | $0.128 | $25.64 | MUMBAI AIR (SAHAR) | BRISBANE | AIR |
| 7 | Nov 2025 | REPUBLIC OF NAURU, DEPARTMENT OF | Australia | Tablet | 200 | NOS | $0.128 | $25.64 | MUMBAI AIR (SAHAR) | BRISBANE | AIR |
10
PART VI — EVIDENCE REGISTER
Indian Supplier Directory
All 25 Indian warfarin exporters — complete list ranked by USD
KEY TAKEAWAY
This directory lists every Indian company that shipped warfarin in 2025-Q4.
S FOR SUPPLIERS
Find yourself and your competitors. Compare shipment count, USD, and destination regions.
B FOR BUYERS
Search for potential Indian suppliers. Filter by dosage form and destination region.
| # | Supplier | City | Ships | USD | Dosage forms | Primary regions |
|---|---|---|---|---|---|---|
| 1 | CIPLA LTD | MUMBAI | 26 | $753K | Tablet | Asia, Africa |
| 2 | AMNEAL PHARMACEUTICALS PVT LTD | RAJODA | 26 | $349K | Tablet, tabsusp | Americas |
| 3 | MACLEODS PHARMACEUTICALS LTD | BADDI | 6 | $69K | Tablet | Americas, Asia |
| 4 | AJANTA PHARMA LTD | MUMBAI | 1 | $33K | Tablet | Asia |
| 5 | NAMAN PHARMA DRUGS | MUMBAI | 1 | $5K | Tablet | Africa |
| 6 | CARIESCO EXPORTS | DAHISAR WEST | 1 | $5K | Tablet | Africa |
| 7 | DREAM PHARMACEUTICAL | AHMEDABAD | 1 | $2K | Tablet | Asia |
| 8 | SCOTT EDIL PHARMACIA LTD | BADDI | 1 | $2K | Tablet | Asia |
| 9 | HLL LIFECARE LTD | UTTAR PRADESH | 4 | $625.44 | Tablet | Africa, Oceania |
| 10 | AFRO LIFESCIENCE | MUMBAI | 9 | $501.36 | Tablet | Africa |
| 11 | SYNERGY TRADING | VADODARA/GUJARAT | 5 | $328.99 | Tablet | Oceania |
| 12 | DERRIC WOOD | SUBHASH PLACE | 37 | $143.06 | Tablet | Asia |
| 13 | PEAK HEALTHCARE | MUMBAI | 6 | $133.37 | Tablet | Americas |
| 14 | JYOTI IMPEX | MUMBAI | 3 | $116.71 | Tablet | Africa |
| 15 | BAKER & DAVIS PVT LTD | MUMBAI | 1 | $109.81 | Tablet | Africa |
| 16 | MEDICOS LIFESCIENCES | AHMEDABAD | 3 | $35.57 | Tablet | Africa |
| 17 | SUBHRA PHARMA PRIAVATE LTD | Navghar Mulund East Mumbai | 1 | $15.60 | Tablet | Americas |
| 18 | NARAYANA HRUDAYALAYA LTD | BANGALORE | 2 | $15.30 | Tablet | Americas |
| 19 | NAMAN GLOBAL IMPEX PVT LTD | MUMBAI | 2 | $8.72 | Tablet | Americas |
| 20 | MOVID IMPEX | MUMBAI | 1 | $2.91 | Tablet | Asia |
| 21 | PREMIER ENTERPRISE | NAGPUR | 1 | $2.61 | Tablet | Asia |
| 22 | M T MADON EXPORTS | MUMBAI | 1 | $2.00 | Tablet | Africa |
| 23 | CURE EARTH PHARMA | Chennai | 1 | $1.39 | Tablet | Africa |
| 24 | AL-SUPREME EXPORTS | NAGERCOIL | 2 | $0.534 | Tablet | Africa |
| 25 | AASHIRWAD PHARMA INTERNATIONAL PVT LTD | PUNE | 1 | $0.014 | Tablet | Americas |
10
PART VI — EVIDENCE REGISTER
Global Buyer Directory
All 22 global warfarin importers — complete list ranked by USD
KEY TAKEAWAY
This directory lists every company that imported Indian warfarin in 2025-Q4.
S FOR SUPPLIERS
Search for potential customers by country and dosage form.
B FOR BUYERS
Find your company and see which Indian supplier serves you.
| # | Buyer | Country | Ships | USD | Primary supplier | Dosage forms |
|---|---|---|---|---|---|---|
| 1 | MEDPRO PHARMACEUTICA PTY LTD | South Africa | 8 | $257K | CIPLA LTD | Tablet |
| 2 | AMNEAL PHARMACEUTICALS LLC | United States | 20 | $247K | AMNEAL PHARMACEUTICA… | Tablet, tabsusp |
| 3 | BREATHEFREE LANKA PVT LTD | Sri Lanka | 8 | $223K | CIPLA LTD | Tablet |
| 4 | PHARMACARE DRUG STORE | Jordan | 3 | $59K | MACLEODS PHARMACEUTI… | Tablet |
| 5 | AJANTA PHARMA PHILIPPINES INC | Philippines | 1 | $33K | AJANTA PHARMA LTD | Tablet |
| 6 | BREATHEFREE LANKA (PVT) LTD | Sri Lanka | 2 | $15K | CIPLA LTD | Tablet |
| 7 | VITAFARMA S.A | Chile | 3 | $9K | MACLEODS PHARMACEUTI… | Tablet |
| 8 | REPUBLIC OF NAURU - DEPARTMENT OF H | Nauru | 2 | $611.96 | HLL LIFECARE LTD | Tablet |
| 9 | CYERDITTRADING CO LTD | Kenya | 1 | $393.71 | AFRO LIFESCIENCE | Tablet |
| 10 | REPUBLIC OF NAURU, DEPARTMENT OF | Australia | 4 | $236.04 | SYNERGY TRADING | Tablet |
| 11 | GOOD HEALTH (PTY) LTD | Seychelles | 5 | $117.24 | JYOTI IMPEX | Tablet |
| 12 | EMIRATES POST COMPANY | United Arab Emirates | 29 | $116.53 | DERRIC WOOD | Tablet |
| 13 | QUEEENS ENTERPRISES CO LTD | Sudan | 1 | $109.81 | BAKER & DAVIS PVT LTD | Tablet |
| 14 | MADAU KUAAC AYAI KON | Sudan | 6 | $80.63 | AFRO LIFESCIENCE | Tablet |
| 15 | LUSAKA PHARMA CHEM SUPPLIES LTD | Zambia | 1 | $18.21 | MEDICOS LIFESCIENCES | Tablet |
| 16 | LUSAKA MEDICAMP LTD | Zambia | 2 | $17.35 | MEDICOS LIFESCIENCES | Tablet |
| 17 | HEALTH CITY CAYMAN ISLANDS (HCCI) | Cayman Islands | 2 | $15.30 | NARAYANA HRUDAYALAYA… | Tablet |
| 18 | MINISTRY OF HEALTH | Seychelles | 2 | $13.48 | HLL LIFECARE LTD | Tablet |
| 19 | EMIRATES POST GROUP | United Arab Emirates | 2 | $5.52 | MOVID IMPEX | Tablet |
| 20 | MOHAMED AHEMED MOHAMUD | Somalia | 1 | $2.00 | M T MADON EXPORTS | Tablet |
| 21 | KALKAAL HOSPITAL | Somalia | 1 | $1.39 | CURE EARTH PHARMA | Tablet |
| 22 | FIRST CHOICE PHARMACY | Dominica | 1 | $0.014 | AASHIRWAD PHARMA INT… | Tablet |
This report covers 143 2025-Q4 Warfarin shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/warfarin
Talk to our trade analyst
Need a custom warfarin report or a deeper dive into any market? Our team is ready.
WhatsApp: +91 95950 78788 · transdatanexus.com
PHARMA TRADE INTELLIGENCE
Thank you for reading
This report is part of the TransData Nexus Pharma Trade Intelligence series, covering 366 pharmaceutical products exported from India.
Every figure is grounded in real commercial trade records — official customs filings and licensed databases. No surveys, no estimates, no fake data.
Need a custom report?
We can generate intelligence for any pharmaceutical product, any time period, any combination of source and destination countries.
Want deeper analysis?
Our team provides competitive intelligence, market entry strategy, and supply chain due diligence for pharma importers and exporters.
Scan for product page
WhatsApp: +91 95950 78788
Email: info@transdatanexus.com
Web: https://transdatanexus.com/pharmaceutical/warfarin
© 2026 TransData Nexus. All rights reserved. This report is provided for informational purposes only.
Data sourced from official customs filings and licensed commercial trade databases.
Reproduction without permission is prohibited.
Explore the full Warfarin product page
Live data, supplier directory, price trends, and trade route analysis